CHUM Hôpital Saint-Luc

Montreal, Quebec H2X 3J4

0 studies enrolling now · 3 studies all time

What they study most

Crohn Disease, Pancreatic Neoplasms, Systemic Lupus Erythematosus

Studies at this site

• Safety Study of Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody in Lupus Nephritis — Stopped early
• Efficacy and Safety Study of Mongersen (GED-0301) for the Treatment of Subjects With Active Crohn's Disease — Stopped early
• Phase 2 Nab® -Paclitaxel (Abraxane®) Plus Gemcitabine in Subjects With Locally Advanced Pancreatic Cancer (LAPC) — Completed